Insulet Corp. (PODD)
175.04
+2.90
(+1.68%)
USD |
NASDAQ |
May 01, 16:00
175.02
-0.02
(-0.01%)
After-Hours: 20:00
Insulet EPS Diluted (Quarterly) : 1.441 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.897 |
| Abbott Laboratories | 0.6165 |
| Intuitive Surgical, Inc. | 2.283 |
| Stryker Corp. | 1.93 |
| Tandem Diabetes Care, Inc. | -0.0087 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 101.60M |
| Revenue (Quarterly) | 783.80M |
| Total Expenses (Quarterly) | 682.20M |
| Enterprise Value | 12.61B |
| Gross Profit Margin (Quarterly) | 72.76% |
| Profit Margin (Quarterly) | 12.96% |
| Earnings Yield | 2.00% |
| Operating Earnings Yield | 3.79% |
| Normalized Earnings Yield | 2.673 |